Diabetes Epidemic in India-- A Comprehensive Review of Clinical Features, Management and Remedies
Journal Title: The Pharma Innovation - Year 2012, Vol 1, Issue 2
Abstract
India, the world’s second most populous country, now has more people with type 2 diabetes (more than 50 million) than any other nation. With India having the highest number of diabetic patients in the world, the sugar disease is posing an enormous health problem in the country. Calling India the diabetes capital of the world, the International Journal of Diabetes in Developing Countries says that there is alarming rise in. According to a WHO fact sheet on diabetes, 2004 recorded an estimated 3.4 million deaths due to consequences of high blood sugar. WHO also estimates that 80 per cent of diabetes deaths occur in low- and middle-income countries and projects that such deaths will double between 2005 and 2030. A glance at statistics from Global Data proves one point: that the two countries having the highest diabetes prevalence (India and China) score quite low when it comes to the expenditure on the disease. In fact, India's expenditure on diabetes does not figure among the top 10 countries at all. The situation is compounded by the fact that diabetes is one of the most costly health problems in the world. It is points out that healthcare expenditure on diabetes accounted for 11.6 per cent of the total healthcare expenditure worldwide in 2010. Diabetes also imposes large economic burdens in the form of lost productivity and foregone economic growth. It has been estimated that the global burden of type 2 diabetes mellitus (T2DM) for 2010 would be 285million people (2010) which is projected to increase to 438 million in 2030; a 65 % increase . Similarly, for India this increase is estimated to be 58%, from 51 million people in 2010 to 87 million in 2030. The impacts of T2DM are considerable: as a lifelong disease, it increases morbidity and mortality and decreases the quality of life. At the same time, the disease and its complications cause a heavy economic burden for diabetic patients themselves, their families and society. A better understanding about the cause of a predisposition of Indians to get T2DM is necessary for future planning of healthcare, policy and delivery in order to ensure that the burdens of disease are addressed.
Authors and Affiliations
K. P Kumar, Debjit bhowmik, Shweta Srivastava, Shravan Paswan, Amit Dutta
Keywords
Related Articles
- EP ID EP140400
- DOI -
- Views 79
- Downloads 0
Diabetes Epidemic in India-- A Comprehensive Review of Clinical Features, Management and Remedies
India, the world’s second most populous country, now has more people with type 2 diabetes (more than 50 million) than any other nation. With India having the highest number of diabetic patients in the world, the sugar di...
Transdermal Drug Delivery System: A Review
A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body...
Recent Trends in Liposomes Used As Novel Drug Delivery System
Drug delivery systems have become important tools for the specific delivery of a large number of drug molecules. Since their discovery in the liposomes were recognized as models to study biological membranes and as versa...
Formulation and Evaluation of Buccal Patches of Simvastatin by Using Different Polymers
The objective of this study was to develop mucoadhesive buccal tablets of Simvastatin using mucoadhesive polymers. Simvastatin has short biological half-life (3hr), high first-pass metabolism and poor oral bioavailabilit...
Formulation and Evaluation of Pulsatile Drug Delivery System of Rosuvastatin Calcium Using Different Swelling Polymers
The objective of this study was to develop and evaluate a pulsatile drug delivery system consisting of cores coated with two layers of swelling and rupturable coatings was prepared and evaluated as pulsatile drug deliver...